A unique target identification platform has been developed by BioTroy, employing integerated approaches including multi-omics dissection of microenvironment, functional hypothesis-driven modeling and precise mining, immununological functions characterization, and target validation methods.
Using our BioTroy Engine platform, we have developed first-in-class oncoimmunology therapies with the greatest degree of novelty and translational significance.
